Molecular studies of anti-HLA-A2 using light-chain shuffling: A structural model for HLa antibody binding

Tissue Antigens

Volumn 63, Issue 4, 2004, Pages 345-354

  Watkins, N A ^a   Dafforn, T R ^a   Kuijpers, M ^a   Brown, C ^b   Javid, B ^a   Lehner, P J ^a   Navarrete, C ^b,c   Ouwehand, W H ^a,b,d  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b NHS BLOOD AND TRANSPLANT   (United Kingdom)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^d NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

Anti HLA; Antigen binding site; Light chain shuffling

Indexed keywords

HLA A2 ANTIGEN; HLA ANTIBODY;

ANTIBODY COMBINING SITE; ANTIBODY SPECIFICITY; ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; IMMUNOGLOBULIN GENE; MOLECULAR INTERACTION; NORMAL HUMAN; PRIORITY JOURNAL;

ANTIBODIES, MONOCLONAL; ANTIBODY AFFINITY; ANTIBODY SPECIFICITY; BINDING SITES, ANTIBODY; CLONING, MOLECULAR; CYTOTOXICITY TESTS, IMMUNOLOGIC; EPITOPES; GENE LIBRARY; HLA-A2 ANTIGEN; HUMANS; IMMUNOGLOBULIN FRAGMENTS; PROTEIN STRUCTURE, TERTIARY; STRUCTURAL HOMOLOGY, PROTEIN; T-LYMPHOCYTES, CYTOTOXIC;

EID: 1642482846     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0001-2815.2004.00194.x     Document Type: Article

References (45)

1. Smith G, Spellerberg M, Boulton F, Roelcke D, Stevenson F. The immunoglobulin VH gene, VH4-21, specifically encodes autoanti-red cell antibodies against the I or i antigens. Vox Sang 1995: 68: 231-5.
2. Li Y, Spellerberg MB, Stevenson FK, Capra JD, Potter KN. The I binding specificity of human VH 4-34 (VH 4-21) encoded antibodies is determined by both VH framework region 1 and complementarity determining region 3. J Mol Biol 1996: 256: 577-89.
3. Pascual V, Victor K, Lelsz D et al. Nucleotide sequence analysis of the V regions of two IgM cold agglutinins. Evidence that the VH4-21 gene segment is responsible for the major cross-reactive idiotype. J Immunol 1991: 146: 4385-91.
4. Thompson KM, Sutherland J, Barden G et al. Human monoclonal antibodies against blood group antigens preferentially express a VH4-21 variable region gene-associated epitope. Scand J Immunol 1991: 34: 509-18.
5. Hughes-Jones NC, Bye JM, Gorick BD, Marks JD, Ouwehand WH. Synthesis of Rh Fv phage-antibodies using VH and VL germline genes. Br J Haematol 1999: 105: 811-6.
6. Bye JM, Carter C, Cui Y et al. Germline variable region gene segment derivation of human monoclonal anti-Rh(D) antibodies. Evidence for affinity maturation by somatic hypermutation and repertoire shift. J Clin Invest 1992: 90: 2481-90.
7. Silberstein LE, Litwin S, Carmack CE. Relationship of variable region genes expressed by a human B cell lymphoma secreting pathologic anti-Pr2 erythrocyte autoantibodies. J Exp Med 1989: 168: 1631-43.
8. Siegel DL, Silberstein LE. Expression and characterization of recombinant anti-Rh(D) antibodies on filamentous phage: a model system for isolating human red blood cell antibodies by repertoire cloning. Blood 1994: 83: 2334-44.
9. Perera WS, Moss MT, Urbaniak SJ. V(D)J germline gene repertoire analysis of monoclonal D antibodies and the implications for D epitope specificity. Transfusion 2000: 40: 846-55.
10. Thorpe SJ, Boult CE, Stevenson FK et al. Cold agglutinin activity is common among human monoclonal IgM Rh system antibodies using the V4-34 heavy chain variable gene segment Transfusion 1997: 37: 1111-6.
11. Thorpe SJ, Turner CE, Stevenson FK, Spellerberg MB, Thorpe R, Natvig JB. Human monoclonal antibodies encoded by the V4-34 gene segment show cold agglutinin activity and variable multireactivity which correlates with the predicted charge of the heavy-chain variable region. Immunology 1998: 93: 129-36.
12. Brown J, Poles A, Brown CJ, Contreras M, Navarrete CV. HLA-A, -B and -DR antigen frequencies of the London Cord Blood Bank units differ from those found in established bone marrow donor registries. Bone Marrow Transplant 2000: 25: 475-81.
13. Garboczi DN, Ghosh P, Utz U, Fan QR, Biddison WE, Wiley DC. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature 1996: 384: 134-41.
14. Andersen PS, Stryhn A, Hansen BE, Fugger L, Engberg J, Buus S. A recombinant antibody with the antigen-specific, major histocompatibility complex-restricted specificity of T cells. Proc Natl Acad Sci USA 1996: 93: 1820-4.
15. Aharoni R, Teitelbaum D, Arnon R, Puri J. Immunomodulation of experimental allergic encephalomyelitis by antibodies to the antigen-Ia complex. Nature 1991: 351: 147-50.
16. Chames P, Hufton SE, Coulie PG, Uchanska-Ziegler B, Hoogenboom HR. Direct selection of a human antibody fragment directed against the tumor T-cell epitope HLA-A1-MAGE-A1 from a nonimmunized phage-Fab library. Proc Natl Acad Sci USA 2000: 97: 7969-74.
17. Chames P, Willemsen RA, Rojas G et al. TCR-like human antibodies expressed on human CTLs mediate antibody affinity-dependent cytolytic activity. J Immunol 2002: 169: 1110-8.
18. Watkins NA, Brown C, Hurd C, Navarrete C, Ouwehand WH. The isolation and characterisation of human monoclonal HLA-A2 antibodies from an immune V gene phage display library. Tissue Antigens 2000: 55: 219-28.
19. Epp O, Lattman EE, Schiffer M, Huber R, Palm W. The molecular structure of a dimer composed of the variable portions of the Bence-Jones protein REI refined at 2.0-A resolution. Biochemistry 1975: 14: 4943-52.
20. Fan ZC, Shan L, Guddat LW et al. Three-dimensional structure of an Fv from a human IgM immunoglobulin. J Mol Biol 1992: 228: 188-207.
21. Chen Y, Wiesmann C, Fuh G et al. Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen. J Mol Biol 1999: 293: 865-31.
22. Muller YA, Chen Y, Christinger HW et al. VEGF and the Fab fragment of a humanized neutralizing antibody: crystal structure of the complex at 2.4 A resolution and mutational analysis of the interface. Structure 1998: 6: 1153-67.
23. Roussel A, Spinelli S, Deret S, Navaza J, Aucouturier P, Cambillau C. The structure of an entire noncovalent immunoglobulin kappa light-chain dimer (Bence-Jones protein) reveals a weak and unusual constant domains association. Eur J Biochem 1999: 260: 192-9.
24. Uson I, Pohl E, Schneider TR et al. 1.7 A structure of the stabilized REIv mutant T39K. Application local NCS restraints. Acta Crystallogr D Biol Crystallogr 1999: 55: 1158-67.
25. Fan QR, Mosyak L, Winter CC, Wagtmann N, Long EO, Wiley DC. Structure of the inhibitory receptor for human natural killer cells resembles haematopoietic receptors. Nature 1997: 389: 96-100.
26. Snyder GA, Brooks AG, Sun PD. Crystal structure of the HLA-Cw3 allotype-specific killer cell inhibitory receptor KIR2DL2. Proc Natl Acad Sci USA 1999: 96: 3864-9.
27. Griffin HM, Ouwehand WH. A human monoclonal antibody specific for the leucine-33 (P1A1, HPA-1a) form of platelet glycoprotein IIIa from a V gene phage display library. Blood 1995: 86: 4430-6.
28. Schier R, Bye J, Apell G et al. Isolation of high-affinity monomeric human anti-c-erbB-2 single chain Fv using affinity-driven selection. J Mol Biol 1996: 255: 28-43.
29. Marks JD, Hoogenboom HR, Bonnert TP, Mccafferty J, Griffiths AD, Winter G. By-passing immunization. Human antibodies from V-gene libraries displayed on phage. J Mol Biol 1991: 222: 581-97.
30. Waterhouse P, Griffiths AD, Johnson KS, Winter G. Combinatorial infection and in vivo recombination: a strategy for making large phage antibody repertoires. Nucleic Acids Res 1993: 21: 2265-6.
31. Cook GP, Tomlinson IM. The human immunoglobulin VH repertoire. Immunol Today 1995: 16: 237-42.
32. Bunce M, O'Neill CM, Barnardo MC et al. Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens 1995: 46: 355-67.
33. Watkins NA, Smethurst PA, Allen D, Smith GA, Ouwehand WH. Platelet alphaIIbbeta3 recombinant autoantibodies from the B-cell repertoire of a post-transfusion purpura patient. Br J Haematol 2002: 116: 677-85.
34. Sali A, Blundell TL. Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol 1993: 234: 779-815.
35. Thompson JD, Higgins DG, Gibson TJ. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994: 22: 4673-80.
36. Nicholls A, Sharp KA, Honig B. Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins 1991: 11: 281-96.
37. Van Heyningen V, Brock DJ, Van Heyningen S. A simple method for ranking the affinities of monoclonal antibodies. J Immunol Methods 1983: 62: 147-53.
38. Tomlinson M, Cox JP, Gherardi E, Lesk AM, Chothia C. The structural repertoire of the human V kappa domain. EMBO J 1995: 14: 4628-38.
39. de Wildt RM, Hoet RM, van Venrooij WJ, Tomlinson IM, Winter G. Analysis of heavy and light chain pairings indicates that receptor editing shapes the human antibody repertoire. J Mol Biol 1999: 285: 895-901.
40. Hoet RM, Pieffers M, Stassen MH et al. The importance of the light chain for the epitope specificity of human anti-U1 small nuclear RNA autoantibodies present in systemic lupus erythematosus patients. J Immunol 1999: 163: 3304-12.
41. Ohlin M, Owman H, Mach M, Borrebaeck CA. Light chain shuffling of a high affinity antibody results in a drift in epitope recognition. Mol Immunol 1996: 33: 47-56.
42. Ibrahim SM, Weigert M, Basu C, Erikson J, Radic MZ. Light chain contribution to specificity in anti-DNA antibodies. J Immunol 1995: 155: 3223-33.
43. Wang D, Hubbard JM, Rabat EA. Modeling study of antibody combining sites to (alpha 1-6) dextrans. Predictions of the conformational contribution of VL-CDR3 and J kappa segments to groove-type combining sites. J Biol Chem 1993: 268: 20584-9.
44. Boyington JC, Motyka SA, Schuck P, Brooks AG, Sun PD. Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand. Nature 2000: 405: 537-43.
45. Armour KL, Clark MR, Hadley AG, Williamson LM. Recombinant human IgG molecules lacking Fcgamma receptor I binding and monocyte triggering activities. Eur J Immunol 1999: 29: 2613-24.